COVID-19 Vaccine Acceptance and Access Among Black and Latinx Communities.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 10 2021
Historique:
entrez: 13 10 2021
pubmed: 14 10 2021
medline: 26 10 2021
Statut: epublish

Résumé

Black and Latinx communities have faced disproportionate harm from the COVID-19 pandemic. Increasing COVID-19 vaccine acceptance and access has the potential to mitigate mortality and morbidity from COVID-19 for all communities, including those most impacted by the pandemic. To investigate and understand factors associated with facilitating and obstructing COVID-19 vaccine access and acceptance among Black and Latinx communities. This community-partnered qualitative study conducted semistructured, in-depth focus groups with Black and Latinx participants from March 17 to March 29, 2021, using a secure video conferencing platform. Participants were recruited through emails from local community-based organizations, federally qualified health centers, social service agencies, the New Haven, Connecticut, Health Department, and in-person distribution of study information from community health workers. A total of 8 focus groups were conducted, including 4 in Spanish and 4 in English, with 72 participants from a diverse range of community roles, including teachers, custodial service workers, and health care employees, in New Haven, Connecticut. Data were analyzed from March 17 to July 30, 2021. Interviews were audio-recorded, transcribed, translated, and analyzed using an inductive content analysis approach. Themes and subthemes were identified on the acceptability and accessibility of the COVID-19 vaccine among participants who identified as Black and/or Latinx. Among 72 participants, 36 (50%) identified as Black, 28 (39%) as Latinx, and 8 (11%) as Black and Latinx and 56 (78%) identified as women and 16 (22%) identified as men. Participants described 3 major themes that may represent facilitators and barriers to COVID-19 vaccinations: pervasive mistreatment of Black and Latinx communities and associated distrust; informing trust via trusted messengers and messages, choice, social support, and diversity; and addressing structural barriers to vaccination access. The findings of this qualitative study may impact what health care systems, public health officials, policy makers, health care practitioners, and community leaders can do to facilitate equitable uptake of the COVID-19 vaccine. Community-informed insights are imperative to facilitating COVID-19 vaccine access and acceptance among communities hardest hit by the pandemic. Preventing the further widening of inequities and addressing structural barriers to vaccination access are vital to protecting all communities, especially Black and Latinx individuals who have experienced disproportionate death and loss from COVID-19.

Identifiants

pubmed: 34643719
pii: 2784917
doi: 10.1001/jamanetworkopen.2021.28575
pmc: PMC8515205
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2128575

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Am J Prev Med. 2009 May;36(5):379-84
pubmed: 19211213
BMC Med Ethics. 2017 Mar 1;18(1):19
pubmed: 28249596
JAMA Intern Med. 2021 Feb 1;181(2):157-158
pubmed: 33284328
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Am J Prev Med. 2021 May;60(5):621-628
pubmed: 33745817
MMWR Morb Mortal Wkly Rep. 2021 Jul 16;70(28):985-990
pubmed: 34264911
JAMA. 2020 Nov 24;324(20):2027-2028
pubmed: 33064145
JAMA. 2021 Jul 27;326(4):301-302
pubmed: 34232270
JMIR Mhealth Uhealth. 2020 Sep 21;8(9):e20356
pubmed: 32955455
Am J Public Health. 2015 Dec;105(12):e60-76
pubmed: 26469668
Prev Chronic Dis. 2010 May;7(3):A67
pubmed: 20394706
N Engl J Med. 2020 Sep 17;383(12):e77
pubmed: 32706952
JAMA Netw Open. 2021 Jul 1;4(7):e2117074
pubmed: 34264327
J Med Internet Res. 2020 Jun 11;22(6):e16002
pubmed: 32525482
Health Educ Res. 2009 Feb;24(1):42-8
pubmed: 18203679
Pediatrics. 2020 Jul;146(1):
pubmed: 32540984
Clin Infect Dis. 2021 Feb 09;:
pubmed: 33560346
Matern Child Health J. 2020 Apr;24(4):456-461
pubmed: 31893386
Oncol Nurs Forum. 2014 Sep;41(5):545-7
pubmed: 25158659
Vaccine. 2020 Oct 14;38(44):6941-6953
pubmed: 32943266
Eur J Intern Med. 2021 May;87:106-108
pubmed: 33810941
Glob Health J. 2021 Mar;5(1):51-55
pubmed: 33585053
Health Secur. 2021 Mar-Apr;19(2):223-228
pubmed: 33346721
J Am Geriatr Soc. 2021 Apr;69(4):888-891
pubmed: 33555042
JAMA Intern Med. 2021 Jul 1;181(7):1008-1011
pubmed: 33783471
J Health Care Poor Underserved. 2020;31(4):1515-1519
pubmed: 33416732
JAMA. 2021 Mar 2;325(9):829-830
pubmed: 33512381
N Engl J Med. 2021 Jul 8;385(2):97
pubmed: 33789007
Ethn Health. 2009 Feb;14(1):75-91
pubmed: 19152160
MMWR Morb Mortal Wkly Rep. 2021 Feb 05;70(5):174-177
pubmed: 33539333
JAMA Netw Open. 2021 Mar 1;4(3):e215344
pubmed: 33755164

Auteurs

Lilanthi Balasuriya (L)

Yale National Clinician Scholars Program, Yale University School of Medicine, New Haven, Connecticut.

Alycia Santilli (A)

Community Alliance for Research and Engagement, New Haven, Connecticut.

Jennifer Morone (J)

Yale National Clinician Scholars Program, Yale University School of Medicine, New Haven, Connecticut.
Veterans Administration Health Services Research and Development Center for the Study of Healthcare Innovation, Implementation, and Policy, West Haven, Connecticut.

Jessica Ainooson (J)

Yale School of Public Health, New Haven, Connecticut.

Brita Roy (B)

Yale School of Public Health, New Haven, Connecticut.
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.

Anuli Njoku (A)

Department of Public Health, College of Health and Human ServiceSouthern Connecticut State University, New Haven.

Andrea Mendiola-Iparraguirre (A)

Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.

Kathleen O'Connor Duffany (K)

Yale School of Public Health, New Haven, Connecticut.

Bernard Macklin (B)

Community Alliance for Research and Engagement, New Haven, Connecticut.

Jackson Higginbottom (J)

Yale School of Public Health, New Haven, Connecticut.

Celina Fernández-Ayala (C)

Community Alliance for Research and Engagement, New Haven, Connecticut.

Genesis Vicente (G)

Community Alliance for Research and Engagement, New Haven, Connecticut.

Arjun Venkatesh (A)

Department of Emergency Medicine, Yale University School of Medicine, New Haven, Connecticut.
Center for Outcomes Research and Evaluation, Yale University School of Medicine, New Haven Connecticut.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH